Annual SG&A
$180.15 M
+$37.15 M+25.98%
31 December 2023
Summary:
Castle Biosciences annual selling, general & administrative expenses is currently $180.15 million, with the most recent change of +$37.15 million (+25.98%) on 31 December 2023. During the last 3 years, it has risen by +$132.02 million (+274.29%). CSTL annual SG&A is now at all-time high.CSTL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$50.50 M
-$589.00 K-1.15%
30 September 2024
Summary:
Castle Biosciences quarterly selling, general & administrative expenses is currently $50.50 million, with the most recent change of -$589.00 thousand (-1.15%) on 30 September 2024. Over the past year, it has increased by +$5.88 million (+13.18%). CSTL quarterly SG&A is now -1.15% below its all-time high of $51.09 million, reached on 30 June 2024.CSTL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$860.98 M
+$6.08 M+0.70%
30 September 2024
Summary:
Castle Biosciences TTM selling, general & administrative expenses is currently -$860.98 million, with the most recent change of +$6.08 million (+0.70%) on 30 September 2024. Over the past year, it has dropped by -$1.04 billion (-593.43%). CSTL TTM SG&A is now -1397.64% below its all-time high of $194.17 million, reached on 30 September 2024.CSTL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.0% | +13.2% | -593.4% |
| 3 y3 years | +274.3% | +123.5% | -1224.9% |
| 5 y5 years | +993.8% | +609.1% | -3664.4% |
CSTL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +274.3% | -1.1% | +123.5% | -194.7% | +0.7% |
| 5 y | 5 years | at high | +993.8% | -1.1% | +609.1% | -307.8% | +0.7% |
| alltime | all time | at high | +1080.7% | -1.1% | +1188.8% | -1397.6% | +0.7% |
Castle Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $50.50 M(-1.2%) | $194.17 M(+3.1%) |
| June 2024 | - | $51.09 M(+5.3%) | $188.29 M(+3.5%) |
| Mar 2024 | - | $48.49 M(+10.0%) | $181.88 M(+1.0%) |
| Dec 2023 | $180.15 M(+26.0%) | $44.09 M(-1.2%) | $180.15 M(+3.2%) |
| Sept 2023 | - | $44.62 M(-0.1%) | $174.49 M(+4.8%) |
| June 2023 | - | $44.68 M(-4.5%) | $166.50 M(+4.5%) |
| Mar 2023 | - | $46.76 M(+21.7%) | $159.31 M(+11.4%) |
| Dec 2022 | $143.00 M(+64.9%) | $38.43 M(+4.9%) | $143.00 M(+10.2%) |
| Sept 2022 | - | $36.63 M(-2.3%) | $129.74 M(+12.1%) |
| June 2022 | - | $37.50 M(+23.1%) | $115.71 M(+16.8%) |
| Mar 2022 | - | $30.45 M(+21.0%) | $99.03 M(+14.2%) |
| Dec 2021 | $86.74 M | $25.16 M(+11.4%) | $86.74 M(+13.3%) |
| Sept 2021 | - | $22.59 M(+8.5%) | $76.54 M(+16.6%) |
| June 2021 | - | $20.82 M(+14.7%) | $65.64 M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $18.16 M(+21.4%) | $55.22 M(+14.7%) |
| Dec 2020 | $48.13 M(+61.3%) | $14.96 M(+27.8%) | $48.13 M(+11.9%) |
| Sept 2020 | - | $11.70 M(+12.6%) | $43.02 M(+11.9%) |
| June 2020 | - | $10.39 M(-6.2%) | $38.44 M(+10.2%) |
| Mar 2020 | - | $11.08 M(+12.4%) | $34.87 M(+16.9%) |
| Dec 2019 | $29.84 M(+81.2%) | $9.85 M(+38.3%) | $29.84 M(+23.5%) |
| Sept 2019 | - | $7.12 M(+4.4%) | $24.16 M(+15.3%) |
| June 2019 | - | $6.82 M(+12.8%) | $20.95 M(+14.5%) |
| Mar 2019 | - | $6.05 M(+45.2%) | $18.29 M(+11.0%) |
| Dec 2018 | $16.47 M(+7.9%) | $4.17 M(+6.3%) | $16.47 M(+33.8%) |
| Sept 2018 | - | $3.92 M(-5.8%) | $12.31 M(+46.7%) |
| June 2018 | - | $4.16 M(-1.6%) | $8.39 M(+98.4%) |
| Mar 2018 | - | $4.23 M | $4.23 M |
| Dec 2017 | $15.26 M | - | - |
FAQ
- What is Castle Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Castle Biosciences?
- What is Castle Biosciences annual SG&A year-on-year change?
- What is Castle Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Castle Biosciences?
- What is Castle Biosciences quarterly SG&A year-on-year change?
- What is Castle Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Castle Biosciences?
- What is Castle Biosciences TTM SG&A year-on-year change?
What is Castle Biosciences annual selling, general & administrative expenses?
The current annual SG&A of CSTL is $180.15 M
What is the all time high annual SG&A for Castle Biosciences?
Castle Biosciences all-time high annual selling, general & administrative expenses is $180.15 M
What is Castle Biosciences annual SG&A year-on-year change?
Over the past year, CSTL annual selling, general & administrative expenses has changed by +$37.15 M (+25.98%)
What is Castle Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of CSTL is $50.50 M
What is the all time high quarterly SG&A for Castle Biosciences?
Castle Biosciences all-time high quarterly selling, general & administrative expenses is $51.09 M
What is Castle Biosciences quarterly SG&A year-on-year change?
Over the past year, CSTL quarterly selling, general & administrative expenses has changed by +$5.88 M (+13.18%)
What is Castle Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of CSTL is -$860.98 M
What is the all time high TTM SG&A for Castle Biosciences?
Castle Biosciences all-time high TTM selling, general & administrative expenses is $194.17 M
What is Castle Biosciences TTM SG&A year-on-year change?
Over the past year, CSTL TTM selling, general & administrative expenses has changed by -$1.04 B (-593.43%)